ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
69,824.80
-0.44%
S&P 500
5,321.41
0.25%
Dow Jones
39,872.99
0.17%
US Dollar vs Yen
156.358
0.07%
Brent Oil
82.105
-0.41%
Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
登録
該当コードがありません。
から:
次の項目別のソート:
日付受信時刻ニュースソース見出しコード企業名
2024/05/2214 : 33Alliance NewsAlliance NewsGET READY: British Land, Close Brothers, M&S, RS, SSE at 0700 BST
2024/05/2214 : 31Alliance NewsAlliance NewsAlliance News UK - start of day
2024/05/2214 : 30GlobeNewswire Inc.Aalberts N.V.: Aalberts sustained added value margin in challenging market environmentLSE:AALBAalberts
2024/05/2214 : 30GlobeNewswire Inc.Aalberts N.V.: Aalberts sustained added value margin in challenging market environmentEU:AALBAalberts NV
2024/05/2214 : 30GlobeNewswire Inc.OSE Immunotherapeutics and Boehringer Ingelheim expand collaboration to develop first-in-class treatments for cancer and cardio-renal-metabolic diseasesEU:OSEOSE Immunotherapeutics
2024/05/2214 : 30GlobeNewswire Inc.OSE Immunotherapeutics and Boehringer Ingelheim expand collaboration to develop first-in-class treatments for cancer and cardio-renal-metabolic diseasesLSE:0RADOse Immunotherapeutics Sa
2024/05/2214 : 30GlobeNewswire Inc.Aalberts N.V.: Aalberts sustained added value margin in challenging market environmentEU:AALBAalberts NV
2024/05/2214 : 30GlobeNewswire Inc.OSE Immunotherapeutics and Boehringer Ingelheim expand collaboration to develop first-in-class treatments for cancer and cardio-renal-metabolic diseasesTG:6OPOSE Immunotherapeutics
2024/05/2214 : 30GlobeNewswire Inc.OSE Immunotherapeutics et Boehringer Ingelheim étendent leur collaboration pour développer des traitements first-in-class dans le cancer et dans les maladies cardiovasculaires, rénales et métaboliquesEU:OSEOSE Immunotherapeutics
2024/05/2214 : 30GlobeNewswire Inc.OSE Immunotherapeutics and Boehringer Ingelheim expand collaboration to develop first-in-class treatments for cancer and cardio-renal-metabolic diseasesEU:OSEOSE Immunotherapeutics
2024/05/2214 : 30GlobeNewswire Inc.OSE Immunotherapeutics et Boehringer Ingelheim étendent leur collaboration pour développer des traitements first-in-class dans le cancer et dans les maladies cardiovasculaires, rénales et métaboliquesLSE:0RADOse Immunotherapeutics Sa
2024/05/2214 : 30GlobeNewswire Inc.Aalberts N.V.: Aalberts sustained added value margin in challenging market environmentTG:AACAAalberts NV
2024/05/2214 : 30GlobeNewswire Inc.OSE Immunotherapeutics et Boehringer Ingelheim étendent leur collaboration pour développer des traitements first-in-class dans le cancer et dans les maladies cardiovasculaires, rénales et métaboliquesTG:6OPOSE Immunotherapeutics
2024/05/2214 : 30GlobeNewswire Inc.BGHL (EUR): NAV(s)EU:BGHLBoussard And Gavaudan Holding Limited
2024/05/2214 : 30GlobeNewswire Inc.Nextensa offers its shareholders an optional dividendEU:NEXTANextensa SA
2024/05/2214 : 30GlobeNewswire Inc.BGHL (EUR): NAV(s)LSE:BGHLBoussard & Gavaudan Holding Limited
2024/05/2214 : 30GlobeNewswire Inc.BGHL (GBP): NAV(s)LSE:BGHSBoussard & Gavaudan Holding Limited
2024/05/2214 : 30GlobeNewswire Inc.Nextensa propose à ses actionnaires un dividende optionnelLSE:0NUTNextensa
2024/05/2214 : 30GlobeNewswire Inc.Nextensa offers its shareholders an optional dividendLSE:0NUTNextensa
2024/05/2214 : 30GlobeNewswire Inc.BGHL (GBP): NAV(s)EU:BGHSBoussard and Gavaudan Holding
2024/05/2214 : 30GlobeNewswire Inc.Nextensa propose à ses actionnaires un dividende optionnelEU:NEXTANextensa SA
2024/05/2214 : 30GlobeNewswire Inc.Transaction in Own SharesTG:6E2Endeavour Mining Corp
2024/05/2214 : 25GlobeNewswire Inc.Trial carbon capture unit begins operating on Blast Furnace at ArcelorMittal Gent, BelgiumNYSE:BHPBHP Group Limited
2024/05/2214 : 16Business WireHAFNIA LIMITED: Ex-Dividend USD 0.3443 TodayNYSE:HAFNHafnia Ltd
2024/05/2214 : 06Alliance NewsAlliance NewsJapan's trade deficit widens in April, as export growth falls short
2024/05/2214 : 05Business WireKey Information Relating to the Cash Dividend to Be Paid by Cool Company Ltd. (TICKER: CLCO)NYSE:CLCOCool Company LTD
2024/05/2214 : 00Business WireWolters Kluwer lance Twinfield DossierFlow aux Pays-Bas, pour aider les comptables à rationaliser la collecte d'informations sur les clients
2024/05/2214 : 00GlobeNewswire Inc.Start of Day Message
2024/05/2214 : 00GlobeNewswire Inc.Press news: Sequana Medical announces positive outcome of Day 100 meeting with FDA regarding PMA application for alfapump®
2024/05/2214 : 00Business WireCTP to build specialist healthy dog food facility for PsiBufet and Butternut Box at CTPark Zabrze in Poland

最近閲覧した銘柄

BIT
S27023
Societe Generale Effekten
LSE
DC.
Currys
BIT
P129W6
BNP PARIBAS ISSUANCE
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有